A Special Role for Amsacrine in the Treatment of Acute Leukemia
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 7 (6) , 607-609
- https://doi.org/10.3109/07357908909017537
Abstract
(1989). A Special Role for Amsacrine in the Treatment of Acute Leukemia. Cancer Investigation: Vol. 7, No. 6, pp. 607-609. doi: 10.3109/07357908909017537This publication has 10 references indexed in Scilit:
- Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adultsBlood, 1988
- Amsacrine is safe in patients with ventricular ectopyAmerican Journal of Hematology, 1988
- Preventing amsacrine-induced cardiac arrhythmias.Journal of Clinical Oncology, 1987
- A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia.Journal of Clinical Oncology, 1987
- Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemiaCancer Chemotherapy and Pharmacology, 1987
- A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia.Journal of Clinical Oncology, 1987
- Recent Advances in the Biology and Treatment of Acute Lymphoblastic Leukemia in AdultsNew England Journal of Medicine, 1984
- Prolongation of sickle cell survival by dimethyl adipimidate is compromised by immune sensitizationBlood, 1984
- High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.Journal of Clinical Oncology, 1984
- Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsBlood, 1982